Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).
Ambrosy AP, Malik UI, Thomas RC, Parikh RV, Tan TC, Goh CH, Selby VN, Solomon MD, Avula HR, Fitzpatrick JK, Skarbinski J, Philip S, Granowitz C, Bhatt DL, Go AS.
Ambrosy AP, et al. Among authors: thomas rc.
Am Heart J. 2021 May;235:54-64. doi: 10.1016/j.ahj.2021.01.018. Epub 2021 Jan 28.
Am Heart J. 2021.
PMID: 33516752
Free PMC article.